Yee Nelson S, Lee Nikki P
Division of Hematology-Oncology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Experimental Therapeutics Program, Penn State Cancer Institute, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Department of Surgery, The University of Hong Kong, Hong Kong, China.
Biomedicines. 2019 Jan 2;7(1):3. doi: 10.3390/biomedicines7010003.
The identification and development of cancer biomarkers and targets have greatly accelerated progress towards precision medicine in oncology. [...].
癌症生物标志物和靶点的识别与开发极大地加速了肿瘤学精准医学的发展进程。[……]